GlassScriptPhysician profile
Leonardo A Longoria
NPI 1558689554
$5,059.29
in general payments reported to CMS, 2019-2025
26 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,060 · 2020: $255 · 2021: $460 · 2022: $628 · 2023: $231 · 2024: $193 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $655.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,000.00 | 2019 | |
| Abbvie INC. | $437.66 | 2020-2022 | |
| Avion Pharmaceuticals | $227.18 | 2020-2023 | Balcoltra |
| Si-Bone, INC. | $158.77 | 2022 | |
| Coopersurgical, INC. | $149.20 | 2020-2024 | Paragard T 380a, Paragard T 380a |
| Exeltis, USA INC. | $145.08 | 2021-2025 | Slynd |
| Avanos Medical | $139.73 | 2022-2025 | On-Q* Pump and Accessories, On-Q Pump and Accessories |
| Therapeuticsmd, INC. | $122.80 | 2020-2021 | |
| Smith+Nephew, INC. | $95.24 | 2023-2025 | Pico 14, Pico |
| Shield Therapeutics INC | $85.12 | 2023-2025 | Accrufer |
| Merck Sharp & Dohme LLC | $64.95 | 2020-2021 | |
| Astellas Pharma US INC | $58.67 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $51.55 | 2022-2025 | |
| Sage Therapeutics, LLC | $50.76 | 2025 | Zurzuvae |
| Organon LLC | $48.67 | 2021-2025 | Nexplanon |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $40.85 | 2022-2023 | Aptima |
| Baxter Healthcare | $29.09 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $22.40 | 2025 | Kristalose |
| Vertical Pharmaceuticals, LLC | $22.18 | 2019 | |
| Duchesnay USA Incorporated | $21.24 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.83 | 2019 | |
| Agiliti Surgical, INC. | $15.91 | 2020 | |
| Evofem Biosciences, INC. | $15.14 | 2022 | |
| Mission Pharmacal Company | $14.13 | 2021 | |
| Ethicon US, LLC | $13.24 | 2024 | Enseal |
| Genzyme Corporation | $12.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonardo Longoria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.